Biofrontera AG engages in the research, development, and marketing of dermatological products. Its products include Ameluz, BF-RhodolesXepi and Belixos. The company was founded by Hermann Lübbert in 1997 and is headquartered in Leverkusen, Germany.
Like other stocks, B8F shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOFRONTERA AG stock right from TradingView charts — choose your broker and connect to your account.
B8F reached its all-time high on Feb 7, 2007 with the price of 13.101 EUR, and its all-time low was 0.302 EUR and was reached on Mar 4, 2024. See other stocks reaching their highest and lowest prices.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIOFRONTERA AG EBITDA is 2.28 M EUR, and current EBITDA margin is 9.08%. See more stats in BIOFRONTERA AG financial statements.